1-2 of 2
Yang Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial

Yang Xu, Xuzhao Zhang, Dijia Xin, Jiawei Zhang, Luyao Wang, Yili Fan, Boxiao Chen, Wen Lei, Xi Qiu, Huawei Jiang, Xibin Xiao, Liansheng Huang, Jiandong Yu, Xin Yang, Wenjun Yang, Jiangao Zhu, Wenbin Qian
Journal: Cancer Immunology Research
Cancer Immunol Res (2025) 13 (1): 23–34.
https://doi.org/10.1158/2326-6066.CIR-24-0051
Published: 09 January 2025
View article titled, CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
Open the PDF for CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial in another window
Includes: Supplementary data
Journal Articles

SRC-3 Functions as a Coactivator of T-bet by Regulating the Maturation and Antitumor Activity of Natural Killer Cells

Mengjia Hu, Yukai Lu, Yan Qi, Zihao Zhang, Song Wang, Yang Xu, Fang Chen, Yong Tang, Shilei Chen, Mo Chen, Changhong Du, Mingqiang Shen, Fengchao Wang, Yongping Su, Youcai Deng, Junping Wang
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (9): 1150–1162.
https://doi.org/10.1158/2326-6066.CIR-20-0181
Published: 01 September 2020
View article titled, SRC-3 Functions as a Coactivator of T-bet by Regulating the Maturation and Antitumor Activity of Natural Killer Cells
Open the PDF for SRC-3 Functions as a Coactivator of T-bet by Regulating the Maturation and Antitumor Activity of Natural Killer Cells in another window
Includes: Supplementary data